Request Demo
Last update 23 Jan 2025
Suzhou Zanrong Pharmaceutical Technology Co. Ltd.
Last update 23 Jan 2025
Overview
Basic Info
Introduction Suzhou Zanrong Pharmaceutical Technology Co. Ltd., established in 2018, is a biotech company based in Hong Kong, engaged in the clinical-stage development of innovative small-molecule oncology drugs. With R&D divisions in both Shanghai and Suzhou, the company leverages its strengths in DMPK (Drug Metabolism and Pharmacokinetics) to design and develop differentiated "best-in-class" and "first-in-class" therapeutics, addressing substantial unmet clinical needs. |
Tags
Neoplasms
Skin and Musculoskeletal Diseases
Small molecule drug
Disease domain score
A glimpse into the focused therapeutic areas
Technology Platform
Most used technologies in drug development
Targets
Most frequently developed targets
Related
Target |
Mechanism |
Active Org. |
Originator Org. |
Active Indication |
Inactive Indication |
Drug Highest Phase |
First Approval Ctry. / Loc. |
First Approval Date |
Target |
Mechanism |
Active Org. |
Originator Org. |
Active Indication |
Inactive Indication |
Drug Highest Phase |
First Approval Ctry. / Loc. |
First Approval Date |
CTR20200987
一项评价ZN-A-1041肠溶胶囊单药或联合给药在HER2阳性晚期实体瘤患者中的安全性、耐受性、药代动力学与有效性的I期临床研究
[Translation] A Phase I clinical study to evaluate the safety, tolerability, pharmacokinetics and efficacy of ZN-A-1041 enteric-coated capsules alone or in combination in patients with HER2-positive advanced solid tumors
NCT04487236
A Phase 1 Clinical Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Efficacy of ZN-A-1041 Enteric Capsules as a Single Agent or in Combination in Patients With HER2-Positive Advanced Solid Tumors
NCT05593094
A Phase 1 Clinical Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Efficacy of ZN-A-1041 Enteric Capsules as a Single Agent or in Combination in Patients With HER2-Positive Advanced Solid Tumors
100 Clinical Results associated with Suzhou Zanrong Pharmaceutical Technology Co. Ltd.
Login to view more data
Login to view more data
100 Deals associated with Suzhou Zanrong Pharmaceutical Technology Co. Ltd.
Login to view more data
100 Translational Medicine associated with Suzhou Zanrong Pharmaceutical Technology Co. Ltd.
Login to view more data
Corporation Tree
Boost your research with our corporation tree data.
login
or
Pipeline
Pipeline Snapshot as of 05 Mar 2025
The statistics for drugs in the Pipeline is the current organization and its subsidiaries are counted as organizations,Early Phase 1 is incorporated into Phase 1, Phase 1/2 is incorporated into phase 2, and phase 2/3 is incorporated into phase 3
Phase 1 Clinical
2
Login to view more data
Current Projects
Login to view more data
Deal
Boost your decision using our deal data.
login
or
Translational Medicine
Boost your research with our translational medicine data.
login
or
Profit
Explore the financial positions of over 360K organizations with Synapse.
login
or
Grant & Funding(NIH)
Access more than 2 million grant and funding information to elevate your research journey.
login
or
Investment
Gain insights on the latest company investments from start-ups to established corporations.
login
or
Financing
Unearth financing trends to validate and advance investment opportunities.
login
or
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free